Atomistry » Chlorine » PDB 5jzl-5k92 » 5k4j
Atomistry »
  Chlorine »
    PDB 5jzl-5k92 »
      5k4j »

Chlorine in PDB 5k4j: Crystal Structure of CDK2 in Complex with Compound 22

Enzymatic activity of Crystal Structure of CDK2 in Complex with Compound 22

All present enzymatic activity of Crystal Structure of CDK2 in Complex with Compound 22:
2.7.11.22;

Protein crystallography data

The structure of Crystal Structure of CDK2 in Complex with Compound 22, PDB code: 5k4j was solved by J.Yin, W.Wang, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 36.91 / 1.60
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 53.646, 71.681, 72.197, 90.00, 90.00, 90.00
R / Rfree (%) 17.5 / 22.3

Other elements in 5k4j:

The structure of Crystal Structure of CDK2 in Complex with Compound 22 also contains other interesting chemical elements:

Fluorine (F) 1 atom

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of CDK2 in Complex with Compound 22 (pdb code 5k4j). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of CDK2 in Complex with Compound 22, PDB code: 5k4j:

Chlorine binding site 1 out of 1 in 5k4j

Go back to Chlorine Binding Sites List in 5k4j
Chlorine binding site 1 out of 1 in the Crystal Structure of CDK2 in Complex with Compound 22


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of CDK2 in Complex with Compound 22 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl301

b:89.7
occ:1.00
CL1 A:6QB301 0.0 89.7 1.0
C28 A:6QB301 1.7 58.3 1.0
C27 A:6QB301 2.7 58.1 1.0
C29 A:6QB301 2.7 50.3 1.0
F31 A:6QB301 3.0 51.3 1.0
N A:GLY16 3.0 41.1 1.0
CA A:GLY16 3.2 30.7 1.0
CE1 A:TYR15 3.3 56.4 1.0
CD1 A:TYR15 3.3 62.3 1.0
CA A:GLY13 3.4 51.1 1.0
C A:GLY16 3.5 36.8 1.0
N A:GLY13 3.6 50.7 1.0
O A:GLY16 3.6 36.9 1.0
CE A:LYS33 3.7 51.4 1.0
C A:TYR15 3.8 53.9 1.0
C26 A:6QB301 4.0 47.8 1.0
C A:GLY13 4.0 62.0 1.0
CZ A:TYR15 4.0 66.1 1.0
C30 A:6QB301 4.0 44.5 1.0
CG A:TYR15 4.1 66.2 1.0
N A:TYR15 4.1 73.6 1.0
CA A:TYR15 4.4 65.0 1.0
N A:VAL17 4.4 23.9 1.0
N A:THR14 4.5 79.5 1.0
O A:TYR15 4.5 52.3 1.0
C25 A:6QB301 4.5 39.2 1.0
O A:GLY13 4.5 52.5 1.0
NZ A:LYS33 4.5 47.2 1.0
CE2 A:TYR15 4.6 70.1 1.0
CD2 A:TYR15 4.7 67.9 1.0
OH A:TYR15 4.7 64.2 1.0
C A:GLU12 4.7 48.3 1.0
CB A:TYR15 4.8 66.8 1.0
CG A:LYS33 4.9 19.6 1.0
CD A:LYS33 4.9 40.0 1.0

Reference:

J.F.Blake, M.Burkard, J.Chan, H.Chen, K.J.Chou, D.Diaz, D.A.Dudley, J.J.Gaudino, S.E.Gould, J.Grina, T.Hunsaker, L.Liu, M.Martinson, D.Moreno, L.Mueller, C.Orr, P.Pacheco, A.Qin, K.Rasor, L.Ren, K.Robarge, S.Shahidi-Latham, J.Stults, F.Sullivan, W.Wang, J.Yin, A.Zhou, M.Belvin, M.Merchant, J.Moffat, J.B.Schwarz. Discovery of (S)-1-(1-(4-Chloro-3-Fluorophenyl)-2-Hydroxyethyl) -4-(2-((1-Methyl-1H-Pyrazol-5-Yl)Amino)Pyrimidin-4-Yl) Pyridin-2(1H)-One (Gdc-0994), An Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development. J.Med.Chem. V. 59 5650 2016.
ISSN: ISSN 0022-2623
PubMed: 27227380
DOI: 10.1021/ACS.JMEDCHEM.6B00389
Page generated: Sat Dec 12 11:55:33 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy